Outsourcing safety.
- Published in:
- 2009
- Publication type:
- Editorial
Works matching DE "PHARMACEUTICAL industry exports %26 imports"
Results: 21
1
2
Manufacturing and export provisions: Impact on the competitiveness of European pharmaceutical manufacturers and on the creation of jobs in Europe.
- Published in:
- Journal of Generic Medicines, 2014, v. 11, n. 1/2, p. 35, doi. 10.1177/1741134314553606
- By:
- Publication type:
- Article
3
The Effect of the Export of Environmentally Friendly Business Strategies Based on Competitive Advantages in the Pharmaceutical Industry Exports.
- Published in:
- International Journal of Scientific Management & Development, 2016, v. 4, n. 6, p. 221
- By:
- Publication type:
- Article
4
Patents or patients?
- Published in:
- 2013
- Publication type:
- Opinion
5
Generics boost.
- Published in:
- Chemistry & Industry, 2013, v. 77, n. 6, p. 45, doi. 10.1002/cind.7706_14.x
- By:
- Publication type:
- Article
6
Threat from EU rules?
- Published in:
- 2012
- Publication type:
- Opinion
7
Managing the Gray Market in the European Union: The Case of the Pharmaceutical Industry.
- Published in:
- Journal of International Marketing, 1995, v. 3, n. 3, p. 11, doi. 10.1177/1069031X9500300303
- By:
- Publication type:
- Article
8
Exploring the Determinants of Export Performance of Indian Pharmaceutical Industry - A Quantile Regression Approach.
- Published in:
- Journal of Contemporary Research in Management, 2014, v. 9, n. 4, p. 15
- By:
- Publication type:
- Article
9
Deal watch: Co-promotion deals: panacea or poison pill?
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 11, p. 831, doi. 10.1038/nrd3310
- By:
- Publication type:
- Article
10
OVERCOMING COMPLEXITIES OF CLINICAL TRIAL SUPPLIES IN LATIN AMERICA.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 9/10, p. 20
- By:
- Publication type:
- Article
11
REPORT: CLINICAL TRIAL SUPPLIES MARKET WORTH $3.3 BILLION BY 2025.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 9/10, p. 17
- Publication type:
- Article
12
The WTO Legality of the EU's GSP+ Arrangement.
- Published in:
- Journal of International Economic Law, 2007, v. 10, n. 4, p. 869, doi. 10.1093/jiel/jgm035
- By:
- Publication type:
- Article
13
The Doha Round's Public Health Legacy: Strategies for the Production and Diffusion of Patented Medicines under the Amended TRIPS Provisions†.
- Published in:
- Journal of International Economic Law, 2007, v. 10, n. 4, p. 921, doi. 10.1093/jiel/jgm040
- By:
- Publication type:
- Article
14
From Progressive Liberalization to Progressive Regulation in WTO Law.
- Published in:
- Journal of International Economic Law, 2006, v. 9, n. 4, p. 779, doi. 10.1093/jiel/jgl029
- By:
- Publication type:
- Article
15
Why the Japanese Don't Export More Pharmaceuticals: Health Policy as Industrial Policy.
- Published in:
- California Management Review, 1990, v. 32, n. 2, p. 124, doi. 10.2307/41166609
- By:
- Publication type:
- Article
16
Proceedings of Panel Discussion on Strategy for boosting Drugs Exports.
- Published in:
- 2016
- Publication type:
- Proceeding
17
Need for collective efforts to promote drug exports.
- Published in:
- Pulse International, 2015, v. 16, n. 9, p. 11
- Publication type:
- Article
18
Risks and Benefits of Importing Prescription Medications From Lower-Income Countries.
- Published in:
- JAMA: Journal of the American Medical Association, 2008, v. 300, n. 12, p. 1453, doi. 10.1001/jama.300.12.1453
- By:
- Publication type:
- Article
19
Competition in prescription drug markets: is parallel trade the answer?
- Published in:
- Managerial & Decision Economics, 2010, v. 31, n. 5, p. 325, doi. 10.1002/mde.1486
- By:
- Publication type:
- Article
20
The Trans-Pacific Partnership: The Death-Knell of Generic Pharmaceuticals?
- Published in:
- Vanderbilt Journal of Transnational Law, 2016, v. 49, n. 3, p. 853
- By:
- Publication type:
- Article
21
Medicine our biggest high-tech export.
- Published in:
- Australian Journal of Pharmacy, 2013, v. 94, n. 1115, p. 13
- Publication type:
- Article